Iron-Doped Hydroxyapatite Nanoparticles for Magnetic Guided siRNA Delivery.

Area of Science:

• Biomaterials Science
• Nanotechnology
• Gene Therapy

Background:

• Small interfering RNAs (siRNAs) are promising gene therapy agents but face challenges like enzymatic degradation and poor delivery.
• Nanoparticle (NP) delivery systems are explored to enhance siRNA stability and efficacy.
• Magnetic nanoparticles offer unique advantages for targeted delivery and theranostics.

Purpose of the Study:

• To investigate the potential of iron-doped hydroxyapatite nanoparticles (FeHA NPs) for delivering therapeutic siRNAs.
• To evaluate the siRNA loading efficiency, stability, and release profile of FeHA NPs.
• To explore the feasibility of using FeHA NPs for magnetically guided siRNA delivery.

Main Methods:

• Synthesis and characterization of iron-doped hydroxyapatite nanoparticles (FeHA NPs) stabilized by citrate.
• Study of siRNA adsorption kinetics and efficiency onto FeHA NPs.
• Assessment of nanoparticle properties and colloidal stability after siRNA loading.
• Evaluation of in vitro siRNA release profile from loaded FeHA NPs.

Main Results:

• Citrate-stabilized FeHA NPs (Cit-FeHA NPs) demonstrated rapid and high-efficiency (approx. 90%) adsorption of model therapeutic siRNA.
• siRNA loading did not negatively impact the physicochemical properties or colloidal stability of the nanoparticles.
• The siRNA-loaded Cit-FeHA NPs exhibited a sustained release profile over 45 days without evidence of siRNA degradation.
• FeHA NPs showed good biocompatibility and magnetic susceptibility.

Conclusions:

• FeHA NPs are suitable for efficient adsorption and sustained release of therapeutic siRNAs.
• Cit-FeHA NPs represent a promising platform for magnetically guided siRNA delivery systems.
• This study provides preliminary validation for the use of FeHA NPs in advanced gene therapy applications.